2014-03-11 09:41:01 - Hormone Replacement Therapy (HRT): A Global Strategic Business Report - a new market research report on companiesandmarkets.com
Aging population spurs growth in the hormone replacement therapy market. Global market for Hormone Replacement Therapy (HRT) is projected to exceed US$3.3 billion by 2020, driven by rising number of women in the menopausal age, and increase in patient awareness levels.Hormone Replacement Therapy refers to use of hormones - estrogens and progestin for alleviating symptoms associated with menopause. HRT represents a highly challenging market for drug manufacturers, mainly due to safety issues surrounding usage of synthetic sources of estrogen. While safety concerns and legal challenges continue to threaten growth prospects in the global HRT market, manufacturers have been active in addressing some of the health concerns by developing ultra-low and low dose drug versions. Although not backed or supported by
significant clinical data for validating their safety, the low-dose versions, when used for shorter periods, have been successful in addressing a part of the unmet needs and have buoyed the HRT market in recent years.Growth in the HRT market is also constrained by increasing competition from generics, bioidentical hormones, custom compounded medications and competition from non-hormonal products. However, new product approvals and growth opportunities from emerging countries are expected to drive the market in the foreseeable future.HRT products are available in various forms, such as oral tablets, vaginal tablets and rings, transdermal patches, syringes, sprays, vaginal cream, intrauterine systems as well as combination products. Oral formulations are giving way to topical formulations in estrogen therapy. Transdermal systems currently account for a nominal share in the US hormone replacement therapy market. However, their popularity and use is expected to increase in the coming years as physicians realize the higher safety aspects associated with these products when compared to oral formulations. Also, emergence of new products is expected to fuel transition towards transdermal products. Meanwhile, transdermal estrogen products are hugely popular in Europe, with the segment accounting for major share of the estrogen market.The United States represents the single largest market worldwide. Asia-Pacific represents the market with the highest growth potential. Growth in the region is being led by improving healthcare expenditure, rising life expectancies, and increase in the number of research studies focused on ascertaining the advantages of HRT for postmenopausal indications.Key players operating in the market include Abbott Laboratories, AbbVie Inc., Actavis Plc, Bayer Pharma AG, Hisamitsu Pharmaceutical Co Inc., Noven Pharmaceuticals Inc., Novartis AG, Novo Nordisk A/S, Orion Corporation, Pfizer Inc., Rottapharm Madaus, Teva Pharmaceutical Industries Ltd., and Upsher-Smith Laboratories Inc., among others.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.